Cargando…

Combining a Universal Telomerase Based Cancer Vaccine With Ipilimumab in Patients With Metastatic Melanoma - Five-Year Follow Up of a Phase I/IIa Trial

BACKGROUND: Ipilimumab improves survival for patients with metastatic malignant melanoma. Combining a therapeutic cancer vaccine with ipilimumab may increase efficacy by providing enhanced anti-tumor immune responses. UV1 consists of three synthetic long peptides from human telomerase reverse transc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aamdal, Elin, Inderberg, Else Marit, Ellingsen, Espen Basmo, Rasch, Wenche, Brunsvig, Paal Fredrik, Aamdal, Steinar, Heintz, Karen-Marie, Vodák, Daniel, Nakken, Sigve, Hovig, Eivind, Nyakas, Marta, Guren, Tormod Kyrre, Gaudernack, Gustav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147687/ https://www.ncbi.nlm.nih.gov/pubmed/34046035 http://dx.doi.org/10.3389/fimmu.2021.663865

Ejemplares similares

Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
por: Ellingsen, Espen Basmo, et al.
Publicado: (2022)

Long-Term Outcomes of a Phase I Study With UV1, a Second Generation Telomerase Based Vaccine, in Patients With Advanced Non-Small Cell Lung Cancer
por: Brunsvig, Paal F., et al.
Publicado: (2020)

Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
por: Ellingsen, Espen Basmo, et al.
Publicado: (2022)

Telomerase as a Target for Therapeutic Cancer Vaccines and Considerations for Optimizing Their Clinical Potential
por: Ellingsen, Espen Basmo, et al.
Publicado: (2021)

Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)

Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
por: Ellingsen, Espen Basmo, et al.
Publicado: (2023)

Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
por: Aamdal, E., et al.
Publicado: (2022)

Diversification of Antitumour Immunity in a Patient with Metastatic Melanoma Treated with Ipilimumab and an IDO-Silenced Dendritic Cell Vaccine
por: Sioud, Mouldy, et al.
Publicado: (2016)

Pharmacokinetic analysis of two different docetaxel dose levels in patients with non-small cell lung cancer treated with docetaxel as monotherapy or with concurrent radiotherapy
por: Fr Brunsvig, Paal, et al.
Publicado: (2007)

Personal Cancer Genome Reporter: variant interpretation report for precision oncology
por: Nakken, Sigve, et al.
Publicado: (2018)

High sensitivity assays for docetaxel and paclitaxel in plasma using solid-phase extraction and high-performance liquid chromatography with UV detection
por: Andersen, Anders, et al.
Publicado: (2006)

hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
por: Suso, Else M. Inderberg, et al.
Publicado: (2011)

Assessing quality of life in a randomized clinical trial: Correcting for missing data
por: Gunnes, Nina, et al.
Publicado: (2009)

Phase I trial of EpCAM-targeting immunotoxin MOC31PE, alone and in combination with cyclosporin
por: Andersson, Y, et al.
Publicado: (2015)

The disruptive positions in human G-quadruplex motifs are less polymorphic and more conserved than their neutral counterparts
por: Nakken, Sigve, et al.
Publicado: (2009)

Personalized HLA typing leads to the discovery of novel HLA alleles and tumor‐specific HLA variants
por: Anzar, Irantzu, et al.
Publicado: (2022)

Chromosomal instability and a deregulated cell cycle are intrinsic features of high‐risk gastrointestinal stromal tumours with a metastatic potential
por: Namløs, Heidi Maria, et al.
Publicado: (2023)

Sample-Index Misassignment Impacts Tumour Exome Sequencing
por: Vodák, Daniel, et al.
Publicado: (2018)

Large-scale inference of the point mutational spectrum in human segmental duplications
por: Nakken, Sigve, et al.
Publicado: (2009)

Automated amplicon design suitable for analysis of DNA variants by melting techniques
por: Ekstrøm, Per Olaf, et al.
Publicado: (2015)

Mutational analysis and protein profiling predict drug sensitivity in multiple myeloma cell lines
por: Giliberto, Mariaserena, et al.
Publicado: (2022)

Therapeutic vaccination against autologous cancer stem cells with mRNA-transfected dendritic cells in patients with glioblastoma
por: Vik-Mo, Einar Osland, et al.
Publicado: (2013)

NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
por: Haakensen, Vilde Drageset, et al.
Publicado: (2021)

Identification of genetic variants for clinical management of familial colorectal tumors
por: Dominguez-Valentin, Mev, et al.
Publicado: (2018)

Mitozolomide (NSC 353451), a new active drug in the treatment of malignant melanoma. Phase II trial in patients with advanced disease.
por: Gundersen, S., et al.
Publicado: (1987)

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma
por: Hamid, Omid, et al.
Publicado: (2011)

Immunotherapy with allotumour mRNA-transfected dendritic cells in androgen-resistant prostate cancer patients
por: Mu, L J, et al.
Publicado: (2005)

Genetic variants of prospectively demonstrated phenocopies in BRCA1/2 kindreds
por: Dominguez-Valentin, Mev, et al.
Publicado: (2018)

CellLineMiner: a knowledge portal for human cell lines
por: Nakken, Sigve, et al.
Publicado: (2012)

screenwerk: a modular tool for the design and analysis of drug combination screens
por: Hanes, Robert, et al.
Publicado: (2022)

Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy
por: Dillard, Pierre, et al.
Publicado: (2021)

Studies of the L-myc DNA polymorphism and relation to metastasis in Norwegian lung cancer patients.
por: Tefre, T., et al.
Publicado: (1990)

Characteristics of human tumour xenografts transplanted under the renal capsule of immunocompetent mice.
por: Aamdal, S., et al.
Publicado: (1985)

Results of multigene panel testing in familial cancer cases without genetic cause demonstrated by single gene testing
por: Dominguez-Valentin, Mev, et al.
Publicado: (2019)

Specific quorum sensing-disrupting activity (A(QSI)) of thiophenones and their therapeutic potential
por: Yang, Qian, et al.
Publicado: (2015)

The rainfall plot: its motivation, characteristics and pitfalls
por: Domanska, Diana, et al.
Publicado: (2017)

Thiophenone Attenuates Enteropathogenic Escherichia coli O103:H2 Virulence by Interfering with AI-2 Signaling
por: Witsø, Ingun Lund, et al.
Publicado: (2016)

Clonal evolution in primary breast cancers under sequential epirubicin and docetaxel monotherapy
por: Venizelos, Andreas, et al.
Publicado: (2022)

The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
por: Nakken, Sigve, et al.
Publicado: (2021)

Patterns of genomic evolution in advanced melanoma
por: Birkeland, E., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qt4j8bra5n54gm6msqi9ds90bm